human
noroviru
hunov
respons
outbreak
acut
nonbacteri
gastroenter
worldwid
despit
major
effort
vaccin
effect
therapeut
intervent
viru
chicken
immunoglobulin
igi
base
passiv
immun
shown
effect
strategi
prevent
treat
mani
enter
viral
diseas
develop
highli
effici
bioreactor
gener
high
titer
hunovspecif
igi
chicken
yolk
use
recombin
vesicular
stomat
viru
express
hunov
capsid
protein
antigen
first
demonstr
hunov
protein
highli
express
chicken
cell
infect
subsequ
found
white
leghorn
hen
immun
intramuscularli
trigger
high
level
hunovspecif
yolk
igi
antibodi
purifi
yolk
igi
effici
recogn
hunov
viruslik
particl
vlp
importantli
hunovspecif
igi
effici
block
bind
hunov
vlp
three
type
b
histoblood
group
antigen
hbga
attach
factor
hunov
addit
receptor
block
activ
igi
remain
stabl
temperatur
c
ph
rang
thu
immun
hen
could
costeffect
practic
strategi
largescal
product
antihunov
igi
antibodi
potenti
use
prophylact
therapeut
treatment
hunov
infect
viru
famili
calicivirida
contain
five
establish
genera
noroviru
sapoviru
lagoviru
vesiviru
neboviru
least
six
propos
genera
recoviru
valoviru
bavoviru
nacoviru
minoviru
saloviru
infect
mani
differ
anim
speci
includ
human
agent
enter
pathogen
whose
replic
chief
clinic
manifest
gastroenter
potenti
lifethreaten
diarrhea
exampl
virus
includ
human
noroviru
hunov
porcin
noroviru
bovin
noroviru
human
sapoviru
porcin
sapoviru
recent
discov
tulan
viru
hunov
major
foodand
waterborn
viru
account
nonbacteri
acut
gastroenter
worldwid
percentag
may
underestim
due
studi
develop
highli
effici
bioreactor
largescal
product
chicken
egg
yolk
igi
antibodi
use
antigen
found
hunov
highli
express
chicken
cell
infect
hen
vaccin
induc
high
level
hunovspecif
igi
egg
yolk
interestingli
intramuscular
vaccin
produc
approxim
three
time
hunovspecif
igi
combin
intramuscular
nasal
drop
vaccin
rout
importantli
hunovspecif
igi
produc
vaccin
capabl
block
bind
hunov
vlp
type
b
hbga
receptor
addit
egg
yolk
igi
antibodi
remain
stabl
temperatur
c
ph
rang
data
demonstr
recombin
highli
effect
antigen
largescal
product
hunovspecif
igi
passiv
immun
therapeut
agent
recombin
vesicular
stomat
viru
rvsv
express
human
nov
capsid
protein
previous
construct
laboratori
work
stock
propag
confluent
cell
briefli
cell
flask
infect
multipl
infect
moi
h
absorpt
inoculum
remov
cell
wash
twice
dulbecco
modifi
eagl
medium
dmem
addit
ml
fresh
dmem
supplement
fetal
bovin
serum
infect
cell
incub
c
co
incub
extens
cytopath
effect
cpe
observ
cell
cultur
fluid
harvest
viru
titer
determin
plaqu
assay
vero
cell
thirtyfivemillimet
dish
seed
kindli
provid
dr
qingzhong
yu
usda
ar
athen
ga
infect
multipl
infect
moi
h
absorpt
inoculum
remov
cell
wash
twice
dmem
ml
fresh
dmem
supplement
fetal
bovin
serum
ad
infect
cell
incub
c
indic
interv
aliquot
cell
cultur
fluid
remov
amount
fresh
dmem
ad
back
virusinfect
cell
viru
titer
determin
plaqu
assay
vero
cell
sixwel
plate
seed
cell
per
well
h
incub
c
co
incub
cell
infect
moi
indic
time
point
cell
lyse
lysi
buffer
contain
sodium
dodecyl
sulfat
sd
protein
separ
sdspage
transfer
hybond
ecl
nitrocellulos
membran
amersham
piscataway
nj
usa
mini
transblot
electrophoret
transfer
cell
biorad
hercul
ca
usa
blot
probe
guinea
pig
antihuman
nov
antiserum
gener
gift
dr
xi
jiang
dilut
follow
horseradish
peroxidaseconjug
goat
antiguinea
pig
igg
secondari
antibodi
santa
cruz
biotechnolog
inc
dalla
tx
usa
dilut
blot
develop
supersign
west
pico
chemiluminesc
substrat
thermo
scientif
waltham
usa
expos
kodak
biomax
mr
film
kodak
rochest
ny
usa
harvest
cell
lysat
also
subject
western
blot
use
anti
antibodi
proteintech
rosemont
il
usa
recogn
multipl
speci
includ
human
mous
hamster
chicken
protein
band
scan
quantifi
use
typhoon
phosphorimag
imagequ
tl
softwar
ge
healthcar
piscataway
nj
usa
protein
band
time
point
normal
respect
band
time
point
h
postinfect
cell
highest
express
set
percentag
express
time
point
normal
express
h
postinfect
cell
anim
studi
conduct
strict
accord
usda
regul
recommend
guid
care
use
laboratori
anim
nation
institut
health
approv
ohio
state
univers
institut
anim
care
use
committe
anim
protocol
chicken
hous
cage
insid
highsecur
isol
room
provid
hepafilt
intak
exhaust
air
ohio
agricultur
research
develop
center
ohio
state
univers
anim
care
facil
ohio
state
univers
aaalac
accredit
anim
studi
blood
sampl
collect
chicken
confirm
neg
hunov
antibodi
six
healthi
white
leghorn
chicken
provid
dr
lilburn
depart
anim
scienc
ohio
state
univers
randomli
divid
two
group
three
chicken
per
group
prior
studi
chicken
neg
vsv
hunov
antibodi
chicken
group
immun
intramuscularli
inject
dmem
contain
pfu
three
differ
locat
pector
muscl
chicken
group
ii
immun
combin
intramuscular
intranas
rout
specif
pfu
inject
three
differ
locat
pector
muscl
remain
pfu
use
nasal
drop
vaccin
week
postimmun
chicken
group
ii
boost
pfu
via
intramuscular
combin
intramuscular
intranas
rout
respect
immun
egg
collect
daili
week
postboost
vaccin
addit
hen
observ
daili
abnorm
reaction
egg
collect
one
week
immun
use
neg
control
egg
store
c
igi
extract
purif
vlp
insect
cell
describ
previous
minor
modif
spodoptera
frugiperda
cell
infect
baculoviru
express
hunov
moi
infect
cell
cell
cultur
supernat
harvest
day
postinocul
vlp
purifi
cell
cultur
supernat
cell
lysat
ultracentrifug
wv
sucros
cushion
follow
cscl
isopycn
gradient
gcm
ultracentrifug
purifi
vlp
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
follow
coomassi
blue
stain
protein
concentr
vlp
measur
use
bradford
reagent
sigma
chemic
co
st
loui
mo
usa
igi
extract
purifi
egg
yolk
use
polyethylen
glycol
peg
sigma
st
loui
mo
usa
precipit
method
modif
briefli
egg
yolk
dilut
three
volum
pb
ph
mix
peg
ad
final
concentr
vortex
mixtur
continu
roll
roll
mixer
min
mixtur
centrifug
g
min
c
precipit
debri
remov
subsequ
peg
ad
supernat
final
concentr
sampl
mix
roll
mixer
min
mixtur
centrifug
g
min
c
precipit
pellet
contain
igi
dissolv
ml
pb
precipit
peg
use
procedur
describ
final
pellet
dissolv
ml
pb
filter
filter
store
c
puriti
igi
determin
sdspage
follow
coomassi
blue
stain
standard
elisa
measur
hunovspecif
igi
antibodi
titer
briefli
microtit
plate
coat
purifi
hunov
vlp
antigen
ngwell
incub
overnight
c
block
nonfat
milk
time
serial
dilut
chicken
igi
ad
antigenco
well
incub
c
h
wash
pbst
pb
contain
tween
goat
antichicken
igyhrp
santa
cruz
biotechnolog
ad
h
plate
wash
develop
tmb
optic
densiti
od
nm
determin
use
enzymelink
immunosorb
assay
elisa
plate
reader
igi
preimmun
chicken
yolk
use
control
calcul
amount
total
igi
hunovspecif
igi
standard
curv
setup
well
coat
serial
dilut
pure
chicken
igi
promega
madison
wi
usa
concentr
wash
pbst
goat
antichicken
igyhrp
santa
cruz
biotechnolog
dilut
ad
incub
c
h
bound
hrp
color
substrat
reagent
kirkegaard
perri
laboratori
inc
gaithersburg
maryland
usa
follow
read
signal
intens
nm
epoch
microvolum
spectrophotomet
system
biotek
winooski
vt
usa
result
standard
curv
absorb
use
quantifi
rel
concentr
total
igi
hunovspecif
igi
egg
yolk
coat
plate
either
hunov
vlp
rabbit
antichicken
igi
antibodi
sigma
captur
total
igi
hunovspecif
igi
purifi
igi
egg
yolk
analyz
sdspage
sampl
boil
min
load
buffer
contain
sd
mm
trishcl
ph
glycerol
load
onto
polyacrylamid
gel
protein
visual
coomassi
blue
stain
specif
reaction
chicken
igi
hunov
capsid
protein
examin
western
blot
analysi
purifi
hunov
viruslik
particl
vlp
separ
convent
sdspage
transfer
hybond
ecl
nitrocellulos
membran
amersham
mini
transblot
electrophoret
transfer
cell
biorad
block
nonfat
milk
membran
incub
antihunovspecif
igi
nonspecif
igi
nonfat
milkpb
c
overnight
follow
horseradish
peroxidas
hrp
conjug
goat
antichicken
igi
secondari
antibodi
santa
cruz
biotechnolog
dilut
blot
develop
supersign
west
pico
chemiluminesc
substrat
thermo
scientif
expos
kodak
biomax
mr
film
kodak
salivabas
hbga
bind
block
assay
perform
describ
previous
avoid
potenti
hunovspecif
antibodi
saliva
may
interfer
receptorbind
assay
saliva
sampl
boil
use
assay
boil
human
saliva
sampl
known
hbga
phenotyp
b
dilut
coat
microtit
plate
c
overnight
block
nonfat
milk
pb
hunov
vlp
ad
final
concentr
bound
vlp
detect
use
serial
dilut
igi
follow
addit
hrpconjug
goat
antichicken
igi
dilut
color
develop
ad
tetramethylbenzidin
peroxidas
liquid
substrat
kirkegaard
perri
laboratori
stop
min
incub
c
ad
moll
sulfur
acid
optic
densiti
od
measur
nm
use
epoch
microvolum
spectrophotomet
system
biotek
winooski
vt
usa
hbga
block
assay
perform
determin
inhibitori
activ
igi
bind
hunov
vlp
hbga
antigen
boil
human
saliva
sampl
known
hbga
phenotyp
b
dilut
coat
microtit
plate
c
overnight
hunov
vlp
preincub
serial
dilut
igi
h
c
igyvlp
solut
ad
salivaco
well
plate
wash
time
moll
sodium
phosphat
buffer
ph
guinea
pig
antihunov
vlp
antiserum
dilut
ad
incub
h
c
plate
wash
hrpconjug
goat
antiguinea
pig
igg
dilut
ad
incub
h
c
color
develop
ad
tetramethylbenzidin
peroxidas
liquid
substrat
kirkegaard
perri
laboratori
stop
min
incub
c
ad
moll
sulfur
acid
block
rate
calcul
compar
optic
densiti
od
measur
without
block
chicken
igi
igi
chicken
immun
use
control
blank
well
incub
buffer
instead
igyvlp
serv
neg
control
wherea
vlp
bind
carbohydr
absenc
igi
sampl
use
posit
control
ph
stabil
purifi
total
igi
solut
ml
ph
dilut
moll
sodium
phosphat
buffer
ph
ph
solut
adjust
use
either
hcl
naoh
final
ph
rang
solut
incub
c
h
follow
neutral
ad
pb
ph
final
ph
hbga
block
assay
perform
measur
activ
igi
describ
determin
heat
stabil
hunovspecif
igi
purifi
total
igi
solut
ml
ph
treat
temperatur
rang
c
min
heat
treatment
sampl
cool
quickli
ice
hbga
block
assay
perform
measur
activ
igi
describ
quantit
analysi
perform
either
densitometr
scan
autoradiograph
use
typhoon
phosphorimag
imagequ
tl
softwar
ge
healthcar
piscataway
nj
usa
experi
perform
three
six
time
statist
analysi
perform
oneway
multipl
comparison
use
spss
softwar
spss
chicago
il
usa
pvalu
consid
statist
signific
vsv
replic
effici
wide
rang
mammalian
cell
line
previous
show
replic
high
titer
cell
babi
hamster
kidney
cell
chicken
vaccin
first
determin
whether
replic
effici
cell
deriv
chicken
embryo
briefli
cell
infect
moi
kinet
viral
replic
determin
time
point
h
postinfect
shown
figur
replic
effici
cell
viral
titer
gradual
increas
h
postinfect
reach
peak
titer
pfuml
h
postinfect
howev
cell
viru
titer
start
increas
h
postinfect
reach
peak
titer
approxim
h
postinfect
addit
viru
titer
cell
decreas
figur
next
examin
kinet
hunov
express
cell
briefli
cell
infect
moi
cell
lysat
harvest
indic
time
express
determin
western
blot
load
intern
control
express
detect
h
postinfect
cell
line
reach
peak
h
postinfect
figur
hunov
highli
express
cell
h
postinfect
express
decreas
h
postinfect
due
cell
death
quantit
three
independ
experi
show
signific
differ
express
cell
time
point
h
postinfect
p
figur
previous
show
attenu
vitro
vivo
also
trigger
high
level
mucos
humor
cellular
immun
mous
model
sinc
grow
chicken
cell
hypothesi
chicken
suscept
infect
thu
produc
hunovspecif
igi
egg
inocul
chicken
two
rout
intramuscular
combin
intramuscular
intranas
rout
vaccin
safeti
chicken
monitor
daili
abnorm
reaction
observ
chicken
vaccin
rout
recombin
vaccin
affect
feed
intak
egg
product
result
suggest
safe
chicken
vaccin
egg
hen
collect
daili
determin
whether
trigger
hunovspecif
igi
total
igi
purifi
egg
collect
week
postvaccin
examin
puriti
total
igi
total
igi
one
egg
collect
week
postvaccin
analyz
sdspage
shown
figur
two
protein
band
molecular
weight
kda
observ
consist
size
heavi
light
chain
igi
respect
next
determin
whether
purifi
total
igi
contain
hunovspecif
igi
purifi
hunov
vlp
approxim
kda
separ
sdspage
figur
follow
western
blot
use
total
igi
serum
igg
posit
control
band
protein
detect
antihunov
serum
antibodi
rais
guinea
pig
use
figur
neg
control
protein
band
identifi
western
blot
use
total
igi
egg
prior
vaccin
figur
shown
figur
hunov
detect
western
blot
total
igi
egg
collect
week
vaccin
thu
result
confirm
vaccin
trigger
hunovspecif
igi
egg
yolk
blot
use
total
igi
serum
igg
posit
control
band
protein
detect
antihunov
serum
antibodi
rais
guinea
pig
use
figur
neg
control
protein
band
identifi
western
blot
use
total
igi
egg
prior
vaccin
figur
shown
figur
hunov
detect
western
blot
total
igi
egg
collect
week
vaccin
thu
result
confirm
vaccin
trigger
hunovspecif
igi
egg
yolk
next
determin
kinet
hunovspecif
igi
respons
follow
vaccin
briefli
plate
coat
ng
purifi
hunov
vlp
antigen
well
react
serial
dilut
chicken
igi
c
h
react
hrp
label
goat
antichicken
igi
follow
addit
substrat
reagent
elisa
reader
read
od
valu
nm
subsequ
amount
total
igi
hunovspecif
igi
quantifi
use
standard
curv
gener
commerci
avail
igi
shown
figur
amount
hunovspecif
igi
gradual
increas
immun
interestingli
week
postvaccin
level
hunovspecif
igi
intramuscular
vaccin
group
significantli
higher
combin
intramuscular
nasal
drop
vaccin
group
p
week
postvaccin
hunovspecif
igi
intramuscular
group
reach
mgyolk
wherea
mgyolk
hunovspecif
igi
detect
intramuscular
nasal
drop
group
use
similar
method
amount
total
igi
egg
yolk
determin
shown
figur
signific
differ
total
igi
two
vaccin
group
p
addit
signific
differ
total
igi
egg
collect
vaccin
p
experiment
condit
amount
total
igi
yolk
rang
mg
hunov
util
hbga
attach
factor
hunov
vlp
possess
authent
receptor
bind
activ
detect
hbga
bind
assay
assay
human
saliva
contain
hbga
receptor
type
b
synthet
hbga
recogn
hunov
vlp
detect
antihunov
serum
hrpconjug
second
antibodi
therefor
determin
whether
total
igi
deriv
vaccin
hen
could
use
primari
antibodi
hbga
bind
assay
briefli
plate
coat
type
b
human
next
calcul
percentag
hunovspecif
igi
total
igi
egg
yolk
shown
figur
percentag
hunovspecif
igi
gradual
increas
intramuscular
immun
group
contrast
percentag
hunovspecif
igi
rang
combin
immun
group
collect
result
show
immun
rout
capabl
produc
hunovspecif
igi
intramuscular
inject
alon
effect
trigger
hunovspecif
igi
combin
intramuscular
nasal
drop
rout
hunov
util
hbga
attach
factor
hunov
vlp
possess
authent
receptor
bind
activ
detect
hbga
bind
assay
assay
human
saliva
contain
hbga
receptor
type
b
synthet
hbga
recogn
hunov
vlp
detect
antihunov
serum
hrpconjug
second
antibodi
therefor
determin
whether
total
igi
deriv
vaccin
hen
could
use
primari
antibodi
hbga
bind
assay
briefli
plate
coat
type
b
human
saliva
ng
hunov
vlp
ad
bind
hbga
receptor
incub
serial
dilut
total
igi
ad
follow
addit
hrpconjug
goat
antichicken
igi
addit
substrat
reagent
elisa
reader
measur
purifi
total
igi
vaccin
group
strongli
react
hunov
vlp
salivabas
hbga
bind
assay
figur
b
contrast
control
igi
preimmun
hen
neg
assay
overal
total
igi
intramuscular
vaccin
group
significantli
higher
od
valu
combin
vaccin
group
p
compar
od
valu
figur
b
addit
appear
vlp
stronger
bind
activ
type
saliva
compar
type
b
saliva
figur
b
result
demonstr
purifi
total
igi
induc
vaccin
could
use
primari
antibodi
measur
bind
hunov
vlp
three
type
saliva
hbga
bind
assay
saliva
ng
hunov
vlp
ad
bind
hbga
receptor
incub
serial
dilut
total
igi
ad
follow
addit
hrpconjug
goat
antichicken
igi
addit
substrat
reagent
elisa
reader
measur
purifi
total
igi
vaccin
group
strongli
react
hunov
vlp
salivabas
hbga
bind
assay
figur
b
contrast
control
igi
preimmun
hen
neg
assay
overal
total
igi
intramuscular
vaccin
group
significantli
higher
od
valu
combin
vaccin
group
p
compar
od
valu
figur
b
addit
appear
vlp
stronger
bind
activ
type
saliva
compar
type
b
saliva
figur
b
result
demonstr
purifi
total
igi
induc
vaccin
could
use
primari
antibodi
measur
bind
hunov
vlp
three
type
saliva
hbga
bind
assay
next
determin
whether
purifi
igi
potenti
antivir
activ
develop
therapeut
agent
hunov
infect
recent
hbga
block
assay
measur
abil
antibodi
block
bind
hunov
vlp
attach
factor
hbga
develop
presum
blockag
viral
receptor
bind
activ
inhibit
viral
attach
entri
subsequ
viral
infect
thu
assay
serv
use
surrog
assay
serumviru
neutral
assay
briefli
plate
coat
known
saliva
type
b
overnight
vlp
preincub
serial
dilut
igi
h
ad
salivaco
well
guinea
pig
antihunov
vlp
antiserum
ad
follow
addit
hrpconjug
goat
antiguinea
pig
igg
addit
substrat
reagent
measur
elisa
reader
percent
block
activ
calcul
compar
od
valu
measur
without
block
chicken
igi
shown
figur
total
igi
antibodi
isol
egg
yolk
vaccin
group
capabl
block
bind
hunov
vlp
hbga
b
next
determin
whether
purifi
igi
potenti
antivir
activ
develop
therapeut
agent
hunov
infect
recent
hbga
block
assay
measur
abil
antibodi
block
bind
hunov
vlp
attach
factor
hbga
develop
presum
blockag
viral
receptor
bind
activ
inhibit
viral
attach
entri
subsequ
viral
infect
thu
assay
serv
use
surrog
assay
serumviru
neutral
assay
briefli
plate
coat
known
saliva
type
b
c
overnight
vlp
preincub
serial
dilut
igi
c
h
ad
salivaco
well
guinea
pig
antihunov
vlp
antiserum
ad
follow
addit
hrpconjug
goat
antiguinea
pig
igg
addit
substrat
reagent
od
measur
elisa
reader
percent
block
activ
calcul
compar
od
valu
measur
without
block
chicken
igi
shown
figur
total
igi
antibodi
isol
egg
yolk
vaccin
group
capabl
block
bind
hunov
vlp
hbga
b
antigen
dosedepend
manner
serum
dilut
block
activ
approxim
respect
control
igi
purifi
egg
yolk
chicken
immun
detect
block
activ
total
igi
intramuscular
group
significantli
higher
block
activ
compar
intramuscular
nasal
drop
group
p
therefor
igi
vaccin
hen
specif
block
bind
hunov
vlp
hbga
nasal
drop
group
p
therefor
igi
vaccin
hen
specif
block
bind
hunov
vlp
hbga
investig
thermal
stabil
igi
igi
solut
incub
temperatur
rang
min
receptor
block
activ
measur
salivabas
hbga
block
assay
shown
figur
c
hunovspecif
igi
retain
wildtyp
level
investig
thermal
stabil
igi
igi
solut
incub
temperatur
rang
c
min
receptor
block
activ
measur
salivabas
hbga
block
assay
shown
figur
c
hunovspecif
igi
retain
wildtyp
level
block
abil
three
type
saliva
temperatur
c
howev
block
activ
significantli
impair
temperatur
c
p
block
abil
three
type
saliva
temperatur
howev
block
activ
significantli
impair
temperatur
p
next
determin
whether
hunovspecif
igi
stabl
acid
alkalin
environ
purifi
igi
dilut
time
pb
solut
ph
solut
adjust
either
hcl
naoh
final
ph
incub
h
solut
next
determin
whether
hunovspecif
igi
stabl
acid
alkalin
environ
purifi
igi
dilut
time
pb
solut
ph
solut
adjust
either
hcl
naoh
final
ph
incub
c
h
solut
adjust
neutral
ph
receptor
block
activ
measur
hbga
block
assay
shown
figur
c
block
activ
chicken
igi
remain
stabl
ph
h
howev
signific
decreas
block
activ
observ
ph
lower
higher
virus
x
peer
review
assay
shown
figur
c
block
activ
chicken
igi
remain
stabl
ph
h
howev
signific
decreas
block
activ
observ
ph
lower
higher
studi
develop
highli
effici
bioreactor
produc
hunovspecif
igi
egg
yolk
immun
white
leghorn
chicken
recombin
found
intramuscular
immun
alon
effici
trigger
hunovspecif
igi
compar
studi
develop
highli
effici
bioreactor
produc
hunovspecif
igi
egg
yolk
immun
white
leghorn
chicken
recombin
found
intramuscular
immun
alon
effici
trigger
hunovspecif
igi
compar
combin
intramuscular
nasal
drop
immun
hen
demonstr
igi
antibodi
strongli
react
hunov
vlp
elisa
western
blot
hbga
bind
assay
igi
antibodi
capabl
block
hunovhbga
receptor
interact
remain
stabl
temperatur
c
ph
rang
result
suggest
chicken
egg
yolk
igi
antibodi
igi
promis
prophylact
therapeut
agent
hunov
replic
compet
excel
antigen
product
hunovspecif
igi
chicken
natur
host
vsv
cattl
hors
deer
pig
howev
vsv
broad
tissu
tropism
replic
high
titer
mani
mammalian
cell
line
insect
cell
yeast
worm
c
elegan
studi
found
replic
high
titer
cell
continu
cell
line
deriv
chicken
embryo
fibroblast
viru
yield
cell
compar
produc
cell
addit
produc
similar
amount
protein
cell
prior
studi
replic
capabl
vsv
avian
speci
vivo
poorli
understood
report
vsv
infect
chicken
came
studi
rvsvbase
influenza
viru
vaccin
found
chicken
vaccin
rvsv
express
ha
antigen
highli
pathogen
avian
influenza
viru
trigger
high
level
serum
neutral
antibodi
provid
complet
protect
lethal
challeng
avian
influenza
studi
found
hen
vaccin
trigger
high
level
hunovspecif
igi
yolk
support
chicken
suscept
vsv
infect
also
show
immun
rout
affect
igi
product
hen
found
intramuscular
vaccin
trigger
higher
hunovspecif
igi
combin
intramuscular
nasal
drop
vaccin
although
total
igi
level
similar
two
vaccin
rout
rational
includ
nasal
drop
vaccin
may
trigger
higher
mucos
immun
sinc
egg
yolk
develop
reproduct
tract
chicken
fact
previou
mice
studi
show
oral
intranas
vaccin
trig
high
level
serum
mucos
antibodi
one
major
concern
rvsvbase
vaccin
safeti
particularli
sinc
vsv
neurotrop
vsv
infect
rumin
anim
caus
vesicular
lesion
mouth
teat
feet
mice
wild
type
vsv
caus
acut
brain
infect
fatal
enceph
howev
insert
hunov
vsv
vector
significantli
attenu
viru
mous
model
studi
caus
abnorm
reaction
feed
intak
egg
product
chicken
prove
attenu
vivo
although
two
recent
report
show
hunovspecif
igi
induc
hen
vaccin
purifi
vlp
p
particl
insect
cell
use
baculoviru
express
system
studi
repres
first
report
use
live
attenu
recombin
viru
gener
hunovspecif
igi
mani
potenti
advantag
use
live
attenu
igi
product
first
grow
high
titer
wide
rang
cell
line
includ
chicken
cell
second
replic
chicken
result
synthesi
larg
amount
vlp
turn
trigger
high
level
hunov
antibodi
third
econom
timesav
approach
requir
purif
vlp
p
particl
thu
promis
vaccin
antigen
largescal
product
igi
chicken
hunovspecif
igi
potenti
passiv
immun
therapeut
agent
hunov
hunov
lead
caus
viral
gastroenter
worldwid
despit
signific
social
health
econom
burden
caus
fdaapprov
vaccin
therapeut
strategi
avail
epidemiolog
studi
show
hunov
could
caus
lethal
infect
human
particularli
highrisk
popul
infant
young
children
elderli
immunocompromis
individu
thu
need
develop
safe
effect
therapeut
strategi
found
hunovspecif
igi
isol
egg
yolk
biolog
function
vitro
first
hunovspecif
igi
react
vlp
elisa
western
blot
second
similar
serum
igg
hunovspecif
igi
use
primari
antibodi
hbga
bind
assay
third
hunovspecif
igi
control
igi
capabl
block
bind
hunov
vlp
type
b
hbga
human
saliva
although
unknown
whether
hunovspecif
igi
directli
neutral
infecti
hunov
blockag
virusreceptor
interact
like
block
infect
hunov
prevent
hunov
infect
ill
reeck
et
al
found
direct
correl
abil
antibodi
block
vlphbga
bind
protect
hunov
infect
ill
hunov
human
challeng
studi
addit
nurminen
et
al
show
children
could
protect
hunov
infect
due
preexist
hbga
block
antibodi
thu
igi
promis
passiv
immun
approach
prevent
treat
hunov
infect
ill
futur
studi
determin
whether
igi
directli
neutral
infecti
hunov
use
recent
develop
b
cell
cultur
system
human
enteroid
cultur
system
concept
igi
passiv
immun
develop
rotaviru
vivo
anim
model
found
passiv
immun
igi
could
protect
neonat
calv
bovin
rotaviru
induc
diarrhea
mous
model
found
igi
could
prevent
murin
rotaviru
infect
bovin
rotavirusinduc
diarrhea
human
rotavirusinduc
gastroenter
recent
human
rotavirusspecif
igi
administ
oral
milk
supplement
passiv
protect
neonat
pig
enter
human
rotaviru
infect
porcin
epidem
diarrhea
viru
pedv
enter
coronaviru
caus
sever
diarrhea
vomit
mortal
young
piglet
kweon
et
al
found
igi
passiv
immun
protect
piglet
pedv
infect
futur
experi
investig
whether
hunovspecif
igi
protect
gnotobiot
piglet
hunovinduc
gastroenter
viral
shed
chicken
factori
largescal
product
antigenspecif
igi
antibodybas
passiv
immun
therapi
shown
effect
strategi
prevent
infecti
diseas
mani
anim
howev
prepar
serum
antibodi
mammal
expens
timeconsum
thu
largescal
applic
serum
antibodi
limit
igi
egg
yolk
immunoglobulin
deriv
hyperimmun
hen
repres
econom
feasibl
practic
strategi
explor
passiv
treatment
enter
diseas
chicken
igi
product
much
easier
faster
cheaper
method
polyclon
antibodi
product
sourc
easi
rais
chicken
collect
egg
without
involv
stress
procedur
bleed
white
leghorn
chicken
highli
product
lay
egg
continu
produc
egg
contain
antigenspecif
antibodi
yolk
long
time
period
immun
nguyen
et
al
demonstr
chicken
usual
lay
eggsyear
egg
yolk
normal
contain
mg
igi
antigenspecif
antibodi
addit
extract
antibodi
egg
yolk
simpl
noninvas
without
affect
immun
chicken
therefor
chicken
excel
factori
igi
antibodi
product
order
use
immunolog
supplement
infant
formula
food
import
investig
stabil
igi
storag
follow
process
method
involv
thermal
treatment
pasteur
steril
spraydri
base
hbga
block
assay
hunovspecif
igi
remain
stabl
temperatur
c
thu
safe
pasteur
c
igi
human
consumpt
howev
receptor
block
activ
igi
significantli
decreas
temperatur
reach
c
suggest
igi
may
denatur
temperatur
oral
administr
igi
ideal
stabl
acid
alkalin
environ
result
show
receptor
block
activ
igi
decreas
ph
sinc
stomach
ph
may
necessari
encapsul
igi
acid
resist
capsul
releas
intestin
neutral
infecti
viru
particl
exampl
chang
et
al
demonstr
addit
sugar
glycerol
glycin
immunoglobulin
solut
effect
protect
igi
addit
film
coat
gum
arab
proven
effect
reduc
degre
hydrolysi
igi
summari
develop
highli
effici
bioreactor
gener
high
titer
hunovspecif
igi
vaccin
hen
hunovspecif
igi
biolog
activ
captur
hunov
antigen
block
interact
vlp
hbga
studi
facilit
largescal
product
purif
hunovspecif
igi
viru
detect
diagnosi
passiv
immun
therapi
